MAI Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
156,528
+6,773
| +5% | +$727K | 0.12% | 158 |
|
|
2025
Q1 | $15.1M | Sell |
149,755
-34,444
| -19% | -$3.47M | 0.11% | 166 |
|
|
2024
Q4 | $16.5M | Sell |
184,199
-1,001
| -0.5% | -$89.4K | 0.12% | 150 |
|
|
2024
Q3 | $15.5M | Sell |
185,200
-20,753
| -10% | -$1.74M | 0.15% | 116 |
|
|
2024
Q2 | $15.9M | Sell |
205,953
-2,311
| -1% | -$178K | 0.16% | 113 |
|
|
2024
Q1 | $14.3M | Sell |
208,264
-4,604
| -2% | -$315K | 0.15% | 121 |
|
|
2023
Q4 | $12.3M | Sell |
212,868
-6,453
| -3% | -$373K | 0.16% | 118 |
|
|
2023
Q3 | $11.6M | Sell |
219,321
-18,122
| -8% | -$957K | 0.17% | 121 |
|
|
2023
Q2 | $12.8M | Sell |
237,443
-102,959
| -30% | -$5.57M | 0.19% | 110 |
|
|
2023
Q1 | $17M | Buy |
340,402
+1,726
| +0.5% | +$86.4K | 0.27% | 85 |
|
|
2022
Q4 | $15.7M | Buy |
338,676
+2,207
| +0.7% | +$102K | 0.26% | 86 |
|
|
2022
Q3 | $13M | Buy |
336,469
+337
| +0.1% | +$13.1K | 0.24% | 94 |
|
|
2022
Q2 | $12.5M | Sell |
336,132
-13,325
| -4% | -$497K | 0.24% | 91 |
|
|
2022
Q1 | $15.5M | Sell |
349,457
-103,572
| -23% | -$4.59M | 0.26% | 91 |
|
|
2021
Q4 | $19.2M | Buy |
453,029
+2,753
| +0.6% | +$117K | 0.31% | 78 |
|
|
2021
Q3 | $19.5M | Buy |
450,276
+27,153
| +6% | +$1.18M | 0.38% | 74 |
|
|
2021
Q2 | $18.1M | Buy |
423,123
+25,652
| +6% | +$1.1M | 0.36% | 72 |
|
|
2021
Q1 | $15.4M | Buy |
397,471
+29,330
| +8% | +$1.13M | 0.34% | 74 |
|
|
2020
Q4 | $13.2M | Sell |
368,141
-6,438
| -2% | -$231K | 0.33% | 75 |
|
|
2020
Q3 | $14.3M | Buy |
374,579
+109,753
| +41% | +$4.19M | 0.41% | 60 |
|
|
2020
Q2 | $9.3M | Buy |
+264,826
| New | +$9.3M | 0.29% | 78 |
|